| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/31/2011 | US7951556 Mutated prokaryotic cells with high secretion-levels |
| 05/31/2011 | US7951552 Method of preparing non-human tissues for xenotransplantation using α-galactosidase |
| 05/31/2011 | US7951546 Compositions and methods for the diagnosis and treatment of tumor |
| 05/31/2011 | US7951386 Recombinant cytochrome oxidase and/or morula membrane protein for use in developing therapeutics which prevent infection associated with mite parasitfes |
| 05/31/2011 | US7951384 Virus-like particles as vaccines for paramyxovirus |
| 05/31/2011 | US7951380 Methods of stimulating bone growth using ZVEGF4 polypeptides |
| 05/31/2011 | US7951371 Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling |
| 05/31/2011 | US7951370 Anti-TYRP1 antibodies |
| 05/31/2011 | US7951369 Chimeric, human and humanized anti-granulocyte antibodies and methods of use |
| 05/31/2011 | US7951366 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders |
| 05/31/2011 | US7951360 Mutant interleukin-2 (IL-2) polypeptides |
| 05/31/2011 | CA2400929C Antagonistic selective binding agents of osteoprotegerin binding protein |
| 05/31/2011 | CA2323064C Nucleic acid binding proteins |
| 05/26/2011 | WO2011063348A1 Monomeric antibody fc |
| 05/26/2011 | WO2011062926A2 Methods for enhanced protein production |
| 05/26/2011 | WO2011062862A1 Improved bacterial membrane protein secrection |
| 05/26/2011 | WO2011062560A1 Method for producing t cell receptor-like monoclonal antibodies and uses thereof |
| 05/26/2011 | WO2011062298A1 System for increasing gene expression, and vector supporting said system |
| 05/26/2011 | WO2011062112A1 Highly-functional mutant of humanized anti-egfr antibody variable region |
| 05/26/2011 | WO2011061713A1 Method for the production of extracellular glutathione with high yields |
| 05/26/2011 | WO2011061275A1 Production of glycoproteins with low n-glycolylneuraminic acid (neu5gc) content |
| 05/26/2011 | WO2010105097A8 Sparc angiogenic domain and methods of use |
| 05/26/2011 | US20110126301 Dendritic Cell Marker and Uses Thereof |
| 05/26/2011 | US20110124841 Polypeptides Modified by Protein Trans-Splicing Technology |
| 05/26/2011 | US20110124576 Transferrin Variants and Conjugates |
| 05/26/2011 | US20110124570 Fish protein hydrolysate having a bone-stimulating and maintaining activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
| 05/26/2011 | US20110124567 Therapeutic compounds and methods |
| 05/26/2011 | US20110124565 Modified Coagulation Factor VIII With Enhanced Stability and Its Derivatives |
| 05/26/2011 | US20110124516 Polymer Particles and Uses Thereof |
| 05/26/2011 | US20110124048 Methods for Effectively Coexpressing IL-12 and IL-23 |
| 05/26/2011 | US20110124047 Vmp-like sequences of pathogenic borrelia species and strains |
| 05/26/2011 | US20110124046 Extracellular Secretion of Recombinant Proteins |
| 05/26/2011 | US20110124045 Nucleic acids encoding recombinant protein a |
| 05/26/2011 | US20110124024 Proteolysis Resistant Antibody Preparations |
| 05/26/2011 | US20110124016 Diagnosis and Treatment of Malignant Neoplasms |
| 05/26/2011 | US20110123993 Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof |
| 05/26/2011 | US20110123676 Enzymatic treatment of a proteinaceous substrate by enzymatic removal of free thiols |
| 05/26/2011 | US20110123557 Anti-hmga1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of hmga1 |
| 05/26/2011 | US20110123552 Agonistic binding molecules to the human OX40 receptor |
| 05/26/2011 | US20110123539 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 05/26/2011 | US20110123536 Novel human anti-r7v antibodies and uses thereof |
| 05/26/2011 | US20110123532 Method for Making Heteromultimeric Molecules |
| 05/26/2011 | US20110123531 Combination therapy |
| 05/26/2011 | US20110123529 Single domain antibodies directed against epidermal growth factor receptor and uses therefor |
| 05/26/2011 | US20110123527 Method of generating single vl domain antibodies in transgenic animals |
| 05/26/2011 | US20110123487 Therapeutic agents comprising elastic peptides |
| 05/26/2011 | US20110123480 Chimeric proteins and uses thereof |
| 05/26/2011 | US20110123447 Method of providing human tumor-specific antibodies |
| 05/26/2011 | US20110123440 Altered Antibody FC Regions and Uses Thereof |
| 05/26/2011 | CA2781539A1 Monomeric antibody fc |
| 05/26/2011 | CA2781332A1 System for increasing gene expression and vector comprising the system |
| 05/26/2011 | CA2781240A1 Yeast strains producing mammalian-like complex n-glycans |
| 05/26/2011 | CA2781099A1 Improved bacterial membrane protein secrection |
| 05/26/2011 | CA2780487A1 Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
| 05/25/2011 | EP2325319A2 Product and process for transformation of Thraustochytriales microorganisms |
| 05/25/2011 | EP2325317A1 Receptor nucleic acids and polypeptides |
| 05/25/2011 | EP2325316A1 Novel hemopoietin receptor protein, nr10 |
| 05/25/2011 | EP2325296A1 Production of glycoproteins with low N-glycolylneuraminic acid (Neu5Gc) content |
| 05/25/2011 | EP2325204A2 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 05/25/2011 | EP2325203A2 Cadherin materials and methods |
| 05/25/2011 | EP2325202A1 Uses of interferons with altered spatial structure |
| 05/25/2011 | EP2324855A1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 05/25/2011 | EP2324122A1 Production of cellulase enzymes in plant hosts using transient agroinfiltration |
| 05/25/2011 | EP2324121A1 Improved vectors and yeast strains for protein production: ca2+ atpase overexpression |
| 05/25/2011 | EP2324059A1 Anti-pamp therapeutic antibodies |
| 05/25/2011 | EP2324054A2 Phosphopeptides and use of the same |
| 05/25/2011 | EP2324045A2 Photo-crosslinked nucleic acid hydrogels |
| 05/25/2011 | EP1629095B1 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 05/25/2011 | EP1576136B1 Methods for identifying antimicrobial compounds |
| 05/25/2011 | EP1412505B1 Dna sequences for regulating transcription |
| 05/25/2011 | CN1912127B Colibacillus expression carrier and its application |
| 05/25/2011 | CN1772897B Cell factor with several functions |
| 05/25/2011 | CN102076866A Cell line, system and method for optical control of secondary messengers |
| 05/25/2011 | CN102076865A Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation |
| 05/25/2011 | CN102076228A Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan |
| 05/25/2011 | CN102071239A Anti-tumor mung bean polypeptide, preparation method thereof and application thereof to tumors |
| 05/25/2011 | CN102071238A Process for fermenting maltose binding protein-gonadotropin releasing hormone hexamer |
| 05/25/2011 | CN102071212A Lactobacillus NICE system and construction method and application thereof |
| 05/25/2011 | CN102071171A Bifunctional glutathione synthetase and method for producing glutathione by using same |
| 05/25/2011 | CN102070717A Fusion protein, preparation method thereof, DNA sequence for coding protein, expression vector, host cell and protein-containing medicinal compoisition |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070711A Tissue factor pathway inhibitor (TFPI), preparation method thereof and application thereof |
| 05/25/2011 | CN102070703A Methods for preparing purified daptomycin |
| 05/25/2011 | CN102067855A Polyoxin and ningnan mycin compounded pesticide |
| 05/25/2011 | CN102067843A Compound pesticide of tebuconazole and ningnan mycin |
| 05/25/2011 | CN101565681B Mycoplasma hyopneumoniae P36 gene recombined Pichia pastoris and expression protein |
| 05/25/2011 | CN101519450B Fusion protein and use of fusion protein in detection of histoplasma capsulatum |
| 05/25/2011 | CN101392283B Enzymatic hydrolysis method for extracting high F value oligopeptide mixture from rana chensinensis egg oil |
| 05/25/2011 | CN101361972B Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| 05/25/2011 | CN101215595B Method for extracting astaxanthin, protein and chitin from shrimp shell by utilizing microorganism |
| 05/25/2011 | CN101151300B Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions |
| 05/25/2011 | CN101074265B Recombinant anti-TNFR monoclonal antibody, its production and use |
| 05/25/2011 | CN101074262B Recombinant anti-FL moncclonal antibody, its production and use |
| 05/24/2011 | US7947872 Nucleotide sequences involved in plant disease resistance |
| 05/24/2011 | US7947812 Neoplasm specific antibodies and uses thereof |
| 05/24/2011 | US7947810 Kits for diagnosing a hypophosphatemic disorder |
| 05/24/2011 | US7947809 Compositions and methods relating to glucagon receptor antibodies |
| 05/24/2011 | US7947808 Toxin detection method |
| 05/24/2011 | US7947807 Method for obtaining G protein-coupled receptor (GPCR) diffraction-quality crystals employing a monoclonal antibody that binds to the third intracellular loop (IL3) |
| 05/24/2011 | US7947806 Mussel bioadhesive |